Posts
July 16 2025
Onconetix, Inc. announced that they have entered into a definitive merger agreement with Ocuvex Therapeutics, Inc., a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates. EGS acted as counsel to Onconetix, Inc.
July 16 2025
Rani Therapeutics Holdings, Inc. announced the closing of its Registered Direct Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
July 15 2025
Client Alert: New York City Adopts Rules Implementing Paid Prenatal Leave Requirements
The New York City Department of Consumer and Worker Protection (“DCWP”) recently adopted final rules implementing amendments to the Earned Safe and Sick Time Act (“ESSTA”) that incorporate and expand upon New York State’s paid prenatal leave law. These new rules apply to all private-sector NYC employers, regardless of size, and impose new obligations relating to policies, documentation, notices, recordkeeping, and payroll as of July 16, 2025.
Click here to read the alert.
July 15 2025
Colombier Acquisition Corp. II announced the closing of its business combination with Metroplex Trading Company LLC d.b.a. GrabAGun.com, a monumental transaction valuing GrabAGun at $150M and closing with near-zero redemptions from Trust. The go-forward public company is named GrabAGun Digital Holdings Inc. (NYSE: PEW). EGS acted as counsel to Colombier Acquisition Corp. II.
July 15 2025
SEALSQ Corp. announced the closing of its Registered Direct Offering in the amount of $60,000,000. EG&S acted as counsel to the placement agent.
July 14 2025
Nuvve Holdings Corp. announced the closing of its public offering in the amount of $4,800,000. EG&S acted as counsel to the Placement Agent.
July 09 2025
GameSquare Holdings, Inc. announced the closing of its Public Offering in the amount of $9,200,000. EGS acted as counsel to the placement agent.
July 09 2025
Distoken Acquisition Corporation announced the closing of its business combination with YouLife Group Inc. with a pre-money equity value of $700,000,000. EGS acted as counsel to Distoken Acquisition Corporation.